|
| 37864521 | Genomic ancestry in kidney cancer: Correlations with clinical and molecular features. | Cancer | 2024 |
| 37849038 | Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer. | Cancer Discov | 2024 |
| 36529447 | Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations. | Ann Oncol | 2023 |
| 36355783 | Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal Cancer. | Cancer Discov | 2023 |
| 36346689 | NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects. | Clin Cancer Res | 2023 |
| 36007103 | High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer. | Clin Cancer Res | 2023 |
| 36449664 | Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases. | Clin Cancer Res | 2023 |
| 37607324 | Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma. | J Clin Oncol | 2023 |
| 37845474 | Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade. | Nat Med | 2023 |
| 37666264 | First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial. | | 2023 |
| 37738546 | Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer. | JCO Precis Oncol | 2023 |
| 37651310 | Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications. | Cancer Discov | 2023 |
| 37732244 | Deep Learning Model for Tumor Type Prediction using Targeted Clinical Genomic Sequencing Data. | medRxiv | 2023 |
| 37898613 | Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing. | Nat Commun | 2023 |
| 37643132 | Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets. | Clin Cancer Res | 2023 |
| 37561983 | Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors. | JCO Precis Oncol | 2023 |
| 37769223 | Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma. | JCO Precis Oncol | 2023 |
| 37682528 | Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience. | | 2023 |
| 37289003 | The Impact of Germline Alterations in Appendiceal Adenocarcinoma. | Clin Cancer Res | 2023 |
| 36973098 | Inferring genetic ancestry from cancer sequencing data. | | 2023 |
| 36841437 | Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma. | Mod Pathol | 2023 |
| 37149903 | Germline drivers of gynecologic carcinosarcomas. | Gynecol Oncol | 2023 |
| 37084736 | Genomic mapping of metastatic organotropism in lung adenocarcinoma. | Cancer Cell | 2023 |
| 36494075 | Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers. | J Thorac Oncol | 2023 |
| 36493333 | Molecular Classification of Appendiceal Adenocarcinoma. | J Clin Oncol | 2023 |
| 37262391 | Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch Syndrome. | JCO Precis Oncol | 2023 |
| 36746967 | Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers. | Nat Commun | 2023 |
| 36744932 | Comprehensive analysis of germline drivers in endometrial cancer. | J Natl Cancer Inst | 2023 |
| 37436885 | Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry: A Novel Path for Precision Oncology. | Ann Surg | 2023 |
| 36862133 | Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach. | Clin Cancer Res | 2023 |
| 36735656 | Mutant-RB1 circulating tumor DNA in the blood of unilateral retinoblastoma patients: What happens during enucleation surgery: A pilot study. | PLoS One | 2023 |
| 35304457 | The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers. | Nat Commun | 2022 |
| 36048199 | Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort. | Cancer Discov | 2022 |
| 36179682 | Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors. | Cancer Cell | 2022 |
| 36178671 | Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma. | Mol Diagn Ther | 2022 |
| 36044468 | Bioinformatically Expanded Next-Generation Sequencing Analysis Optimizes Identification of Therapeutically Relevant MET Copy Number Alterations in >50,000 Tumors. | Clin Cancer Res | 2022 |
| 36041233 | Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants. | Cancer | 2022 |
| 35970919 | Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer. | Nat Med | 2022 |
| 35705560 | Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets. | Nat Commun | 2022 |
| 36357680 | Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer. | Nat Med | 2022 |
| 35833951 | Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer. | Clin Cancer Res | 2022 |
| 36228155 | Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention. | Clin Cancer Res | 2022 |
| 35383193 | Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers. | Nat Commun | 2022 |
| 35439652 | Evaluation of TERT mRNA expression using RNAscope®: A potential histopathologic diagnostic and prognostic tool. | Pathol Res Pract | 2022 |
| 35377946 | The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma. | Clin Cancer Res | 2022 |
| 35999225 | ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance. | NPJ Breast Cancer | 2022 |
| 35617398 | Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. | Science | 2022 |
| 35797508 | Matched Molecular Profiling of Cell-Free DNA and Tumor Tissue in Patients With Advanced Clear Cell Renal Cell Carcinoma. | JCO Precis Oncol | 2022 |
| 35477182 | Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 36418296 | Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies. | Nat Commun | 2022 |